{
    "id": "dbpedia_4379_0",
    "rank": 28,
    "data": {
        "url": "https://www.gla.ac.uk/schools/healthwellbeing/staff/martintaylor-rowan/",
        "read_more_link": "",
        "language": "en",
        "title": "School of Health & Wellbeing",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.gla.ac.uk/3t4/img/cog-white.svg",
            "https://www.gla.ac.uk/3t4/img/ug-keyline.svg",
            "https://www.gla.ac.uk/3t4/img/ug-keyline-large.svg",
            "https://www.gla.ac.uk/3t4/img/orcid.logo.icon.svg",
            "https://www.gla.ac.uk/3t4/img/marque.svg",
            "https://www.gla.ac.uk/3t4/img/fb.svg",
            "https://www.gla.ac.uk/3t4/img/tw.svg",
            "https://www.gla.ac.uk/3t4/img/inst.svg",
            "https://www.gla.ac.uk/3t4/img/yt.svg",
            "https://www.gla.ac.uk/3t4/img/svh.webp"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/3t4/img/hd_hi.png",
        "meta_site_name": "",
        "canonical_link": "https://www.gla.ac.uk/schools/healthwellbeing/staff/martintaylor-rowan/",
        "text": "Number of items: 50.\n\n2024\n\nWardlaw, J. M. et al. (2024) European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke. European Stroke Journal, 9(1), pp. 5-68. (doi: 10.1177/23969873231219416) (PMID:38380638) (PMCID:PMC10916806)\n\n2023\n\nTaylor-Rowan, M. , Alharthi, A., Noel-Storr, A. H., Myint, P. K., Stewart, C., McCleery, J. and Quinn, T. J. (2023) Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment. Cochrane Database of Systematic Reviews, 2023(12), CD015405. (doi: 10.1002/14651858.CD015405.pub2) (PMID:38063254) (PMCID:PMC10704558)\n\nTaylor-Rowan, M. , Hafdi, M., Drozdowska, B. , Elliott, E., Warlaw, J. and Quinn, T. J. (2023) Physical and brain frailty in ischaemic stroke or TIA: shared occurrence and outcomes. A cohort study. European Stroke Journal, 8(4), pp. 1011-1020. (doi: 10.1177/23969873231186480) (PMID:37421136)\n\nHo, L. et al. (2023) Comparing research priority-setting partnerships for older adults across international health care systems: a systematic review. Journal of the American Medical Directors Association, 24(11), pp. 1726-1745. (doi: 10.1016/j.jamda.2023.09.003) (PMID:37848169)\n\nGallacher, K. I. , Taylor-Rowan, M. , Eton, D. T., McLeod, H. , Kidd, L. , Wood, K., Sardar, A., Quinn, T. J. and Mair, F. S. (2023) Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke. Health Open Research, 5, 17. (doi: 10.12688/healthopenres.13334.1)\n\nFaheem, W. et al. (2023) Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study. European Geriatric Medicine, 14(2), pp. 325-332. (doi: 10.1007/s41999-022-00737-y) (PMID:36696045) (PMCID:PMC10113325)\n\nNaeem, F., Reid, J., Bailey, M., Reid, A., Smyth, C., Taylor-Rowan, M. , Newman, E. J. and Quinn, T. (2023) Pharmacological interventions for sialorrhoea in people with Parkinson's disease: a systematic review and meta-analysis. Movement Disorders Clinical Practice, 10(4), pp. 558-568. (doi: 10.1002/mdc3.13688) (PMID:37070045)\n\nTaylor-Rowan, M. , Nafisi, S., Owen, R., Duffy, R., Patel, A., Burton, J. K. and Quinn, T. J. (2023) Informant-based screening tools for dementia: an overview of systematic reviews. Psychological Medicine, 53(2), pp. 580-589. (doi: 10.1017/S0033291721002002) (PMID:34030753)\n\n2022\n\nTaylor-Rowan, M. , Alharthi, A. A., Noel-Storr, A. H., Myint, P. K., Stewart, C., McCleery, J. and Quinn, T. J. (2022) Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment. Cochrane Database of Systematic Reviews, 2022(12), CD015405. (doi: 10.1002/14651858.cd015405) (PMCID:PMC9730444)\n\nFischer, F. et al. (2022) Comparison of different scoring methods based on latent variable models of the PHQ-9: an individual participant data meta-analysis. Psychological Medicine, 52(15), pp. 3472-3483. (doi: 10.1017/S0033291721000131) (PMID:33612144) (PMCID:PMC9393567)\n\nDawson, J. et al. (2022) European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. European Stroke Journal, 7(3), I-XLI. (doi: 10.1177/23969873221100032) (PMID:36082250) (PMCID:PMC9446324)\n\nDawson, J. et al. (2022) Response to letter by Prof Christian Nolte and colleagues. European Stroke Journal, 7(3), pp. 341-342. (doi: 10.1177/23969873221110378) (PMID:36082263) (PMCID:PMC9446323)\n\nTaylor-Rowan, M. , Kraia, O., Kolliopoulou, C., Noel-Storr, A. H., Alharthi, A. A., Cross, A. J., Stewart, C., Myint, P. K., McCleery, J. and Quinn, T. J. (2022) Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. Cochrane Database of Systematic Reviews, 2022(8), CD015196. (doi: 10.1002/14651858.cd015196.pub2) (PMID:35994403) (PMCID:PMC9394684)\n\nHarel, D. et al. (2022) External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4. Methods, 204, pp. 300-311. (doi: 10.1016/j.ymeth.2021.11.005) (PMID:34780986)\n\nTaylor-Rowan, M. , McGuire, L. , Hafdi, M., Evans, J. , Stott, D. J. , Wetherall, K., Elliott, E., Drozdowska, B. and Quinn, T. J. (2022) Comparative validity of informant tools for assessing pre-stroke cognitive impairment. International Journal of Geriatric Psychiatry, 37(4), pp. 1-10. (doi: 10.1002/gps.5700) (PMID:35278006)\n\nBurton, J. K. , Stewart, J., Blair, M., Oxley, S., Wass, A., Taylor-Rowan, M. and Quinn, T. J. (2022) Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age and Ageing, 51(3), afac064. (doi: 10.1093/ageing/afac064) (PMID:35352795)\n\nJoyce, N. et al. (2022) Frailty and stroke thrombectomy outcomes—an observational cohort study. Age and Ageing, 51(2), afab260. (doi: 10.1093/ageing/afab260) (PMID:35150584)\n\nQuinn, T. J. et al. (2022) Research protocol – Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: a prospective cohort study in stroke. Cerebral Circulation - Cognition and Behavior, 3, 100042. (doi: 10.1016/j.cccb.2022.100042) (PMID:36324404) (PMCID:PMC9616226)\n\n2021\n\nTaylor-Rowan, M. , Kraia, O., Kolliopoulou, C., Cross, A. J., Stewart, C., Myint, P. K., McCleery, J. and Quinn, T. J. (2021) Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia (Protocol). Cochrane Database of Systematic Reviews, 2021(11), CD015196. (doi: 10.1002/14651858.cd015196) (PMCID:PMC8601112)\n\nNegeri, Z. F. et al. (2021) Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183. (doi: 10.1136/bmj.n2183) (PMID:34610915) (PMCID:PMC8491108)\n\nQuin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)\n\nBonati, L. H. et al. (2021) European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. European Stroke Journal, 6(2), I-XLVII. (doi: 10.1177/23969873211012121) (PMID:34414302) (PMCID:PMC8370069)\n\nWardlaw, J. M. et al. (2021) ESO Guideline on covert cerebral small vessel disease. European Stroke Journal, 6(2), CXI-CLXII. (doi: 10.1177/23969873211012132) (PMID:34414301) (PMCID:PMC8370079)\n\nTaylor-Rowan, M. , Edwards, S., Noel-Storr, A. H., McCleery, J., Myint, P. K., Soiza, R., Stewart, C., Loke, Y. K. and Quinn, T. J. (2021) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews, 2021(5), CD013540. (doi: 10.1002/14651858.CD013540.pub2) (PMID:34097766)\n\nQuinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)\n\nGill, D. et al. (2021) Urate, blood pressure, and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials. Hypertension, 77(2), pp. 383-392. (doi: 10.1161/HYPERTENSIONAHA.120.16547) (PMID:33356394) (PMCID:PMC7803439)\n\nStewart, C., Yrjana, K., Kishor, M., Soiza, R. L., Taylor-Rowan, M. , Quinn, T. J. , Loke, Y. K. and Myint, P. K. (2021) Anticholinergic burden measures predict older people's physical function and quality of life: a systematic review. Journal of the American Medical Directors Association, 22(1), pp. 56-64. (doi: 10.1016/j.jamda.2020.05.065) (PMID:32709405)\n\nStewart, C., Taylor-Rowan, M. , Soiza, R. L., Quinn, T. J. , Loke, Y. K. and Myint, P. K. (2021) Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review. Therapeutic Advances in Drug Safety, 12, p. 20420986211016645. (doi: 10.1177/20420986211016645) (PMID:34104401) (PMCID:PMC8170331)\n\n2020\n\nTaylor-Rowan, M. , Nafisi, S., Burton, J. K. and Quinn, T. J. (2020) Informant-based screening tools for diagnosis of dementia, an overview of systematic reviews of test accuracy studies protocol. Systematic Reviews, 9, 271. (doi: 10.1186/s13643-020-01530-3) (PMID:33243282) (PMCID:PMC7694897)\n\nGanesh, A., Taylor-Rowan, M. and Quinn, T. J. (2020) Reader response: Outcomes of patients with stroke treated with thrombolysis according to prestroke Rankin Scale scores. Neurology, 95(11), pp. 506-507. (doi: 10.1212/WNL.0000000000010516) (PMID:32934160)\n\nDrozdowska, B. A. , Elliott, E., Taylor-Rowan, M. , Shaw, R. C., Cuthbertson, G., Langhorne, P. and Quinn, T. J. (2020) Cardiovascular risk factors indirectly affect acute post-stroke cognition through stroke severity and prior cognitive impairment: A moderated mediation analysis. Alzheimer's Research and Therapy, 12, 85. (doi: 10.1186/s13195-020-00653-y) (PMID:32678028) (PMCID:PMC7367370)\n\nLevis, B. et al. (2020) Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression. JAMA: Journal of the American Medical Association, 323(22), pp. 2290-2300. (doi: 10.1001/jama.2020.6504) (PMID:32515813) (PMCID:PMC7284301)\n\nLevis, B. et al. (2020) Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. Journal of Clinical Epidemiology, 122, 115-128.e1. (doi: 10.1016/j.jclinepi.2020.02.002) (PMID:32105798)\n\nGraves-Morris, K., Stewart, C., Soiza, R. L., Taylor-Rowan, M. , Quinn, T. J. , Loke, Y. K. and Myint, P. K. (2020) The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: a systematic review and meta-analysis. Frontiers in Pharmacology, 11, 570. (doi: 10.3389/fphar.2020.00570)\n\nQuinn, T. J. , Myint, P. K., McCleery, J., Taylor-Rowan, M. and Stewart, C. (2020) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews, 2020(2), CD013540. (doi: 10.1002/14651858.cd013540)\n\n2019\n\nGeriatric Medicine Research Collaborative, ., , , , , , and , (2019) Delirium is prevalent in older hospital inpatients and associated with adverse outcomes: results of a prospective multi-centre study on World Delirium Awareness Day. BMC Medicine, 17, 229. (doi: 10.1186/s12916-019-1458-7) (PMID:31837711) (PMCID:PMC6911703)\n\nShaw, R., Drozdowska, B. , Taylor-Rowan, M. , Elliott, E., Cuthbertson, G., Stott, D. J. and Quinn, T. J. (2019) Delirium in an acute stroke setting, occurrence, and risk factors. Stroke, 50(11), pp. 3265-3268. (doi: 10.1161/strokeaha.119.025993) (PMID:31554500)\n\nElliott, E., Drozdowska, B. A. , Taylor-Rowan, M. , Shaw, R. C., Cuthbertson, G. and Quinn, T. J. (2019) Who is classified as untestable on brief cognitive screens in an acute stroke setting? Diagnostics, 9(3), 95. (doi: 10.3390/diagnostics9030095)\n\nTaylor-Rowan, M. , Keir, R., Cuthbertson, G., Shaw, R., Drozdowska, B. , Elliott, E., Evans, J. , Stott J, D. and Quinn, T. J. (2019) Pre-stroke frailty is independently associated with post-stroke cognition: A cross-sectional study. Journal of the International Neuropsychological Society, 25(5), pp. 501-506. (doi: 10.1017/S1355617719000092) (PMID:30821222)\n\nTaylor-Rowan, M. , Momoh, O., Ayerbe, L., Evans, J. J. , Stott, D. J. and Quinn, T. J. (2019) Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis. Psychological Medicine, 49(4), pp. 685-696. (doi: 10.1017/S0033291718002003) (PMID:30107864)\n\nTaylor-Rowan, M. , Cuthbertson, G., Keir, R., Shaw, R., Drozdowska, B. , Elliott, E., Stott, D. and Quinn, T. J. (2019) The prevalence of frailty amongst acute stroke patients, and evaluation of method of assessment. Clinical Rehabilitation, 33(10), pp. 1688-1696. (doi: 10.1177/0269215519841417) (PMID:30971115)\n\n2018\n\nTaylor-Rowan, M. (2018) Pre-Stroke Frailty is Independently Associated with Acute Post-Stroke Cognition: A Cross-Sectional Study. British Geriatrics Society Communications to the Spring Meeting, Nottingham, UK, 11-13 April 2018.\n\nTaylor-Rowan, M. et al. (2018) Assessing the Psychometric Properties of the HIS \"Think Frailty\" Tool. British Geriatrics Society Communications to the Spring Meeting, Nottingham, UK, 11-13 April 2018.\n\nTaylor-Rowan, M. , Wilson, A., Dawson, J. and Quinn, T. J. (2018) Functional assessment for acute stroke trials: properties, analysis, and application. Frontiers in Neurology, 9, 191. (doi: 10.3389/fneur.2018.00191)\n\nTaylor-Rowan, M. et al. (2018) Assessing the psychometric properties of the his \"Think Frailty\" tool. Age and Ageing, 47(S 3), iii20-iii23. (doi: 10.1093/ageing/afy127.02)\n\nTaylor-Rowan, M. (2018) Pre-stroke frailty is independently associated with acute post-stroke cognition: a cross-sectional study. Age and Ageing, 47(S 3), iii28-iii30. (doi: 10.1093/ageing/afy135.08)\n\n2017\n\nQuinn, T. J. et al. (2017) Pre-stroke modified Rankin scale: evaluation of validity, prognostic accuracy and association with treatment. Frontiers in Neurology, 8, 275. (doi: 10.3389/fneur.2017.00275) (PMID:28659859)\n\nMacIsaac, R. L., Ali, M. , Taylor-Rowan, M. , Rodgers, H., Lees, K. R. and Quinn, T. J. (2017) Use of a 3-item short-form version of the Barthel Index for use in stroke. Stroke, 48(3), pp. 618-623. (doi: 10.1161/STROKEAHA.116.014789) (PMID:28154094)\n\nQuinn, T. J., Shaw, R. and Taylor-Rowan, M. (2017) Occurrence (Incidence and Prevalence) Rate of Delirium and Risk Factors in Acute Stroke - Cross-sectional Study. 2017 International Stroke Conference and State-of-the-Science Stroke Nursing Symposium, Houston, TX, USA, 21-24 Feb 2017."
    }
}